Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €12.2 billion and an operating profit (adjusted EBITDA) of €1.91 billion in 2020. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: We want to improve life today and tomorrow.
As a technology leader for high-performance polymers, Evonik supplies PEEK-based (polyether ether ketone) and polyamide-based materials for the medical sector. VESTAKEEP® PEEK for medical applications includes i-Grades for permanent surgical implants, Dental-Grades for temporary and permanent dental applications and Care-Grades for medical devices. Evonik’s new product line of next-generation VESTAKEEP® Fusion with osteoconductive properties extends the material portfolio.
Furthermore, Evonik has been the world’s leading manufacturer of high-performance polymers and additives used in additive manufacturing. The specialty chemicals company offers the industry’s most extensive portfolio biomaterials used in the 3D printing of medical device parts designed for temporary and permanent body contact. In addition to VESTAKEEP® i4 3DF and VESTAKEEP® Care M40 3DF, the portfolio includes the RESOMER® line of bioresorbable filaments, powders and granules for implantable medical devices.
These materials are changing standards for medical technology applications due to their outstanding biocompatibility, biostability and functionality.